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Abstract
Background: Pulmonary histoplasmosis is a mycotic infection that often resembles pulmonary
malignancy and continues to complicate the evaluation of pulmonary nodules.
Case presentation: We report a case of an immunocompetent patient who, despite adequate
treatment for known histoplasmosis lung infection, presented with radiological and F-18
fluorodeoxyglucose (FDG) positron emission tomography (PET) findings mimicking primary lung
malignancy which eventually required surgical resection.
Conclusion: Histoplasmosis infection may radiologically resemble pulmonary malignancy, often
causing a diagnostic dilemma. PET imaging is currently used for and considered accurate in the
evaluation of pulmonary nodules. However, overlap in PET standardized uptake value (SUV)
between granulomatous and malignant lesions decreases the accuracy of PET as a diagnostic
modality. Future advances in PET imaging are needed to improve its accuracy in the evaluation of
pulmonary nodules in areas where histoplasmosis is endemic.
Background
Histoplasma capsulatum is a dimorphic fungus that is
usually found in the mycelial form in its native state and
grows as a yeast at mammalian body temperatures. It was
historically first described by Dr. Samuel Darling in 1906,
using autopsy material obtained from a patient native to
the island of Martinique that died from a wasting febrile
illness. The name Histoplasma capsulatum was given to this
organism since it was found to be present in histiocytes,
and was thought to be an encapsulated plasmodium or
protozoan. It has since been well established that H. cap-
sulatum is not a plasmodium, but rather a dimorphic fun-
gus that is usually found in the soil of endemic areas in
many parts of the world.
The clinical and radiological presentation of pulmonary
histoplasmosis is variable. Often, the infection may
mimic lung neoplasm and may require thoracoscopy or
open lung biopsy to establish a definitive diagnosis. F-18
FDG PET, increasingly used in the assessment of pulmo-
nary nodules, is reevaluated as an accurate imaging
modality in the diagnosis of pulmonary histoplasmosis in
this case presentation.
Case presentation
A 64-year-old fisherman presented to his primary care
physician with fever, chills, and generalized malaise of
three days duration. The patient had recently returned
from a 2 week vacation to Guatemala and Belize. His
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medical history included prostate cancer and hyperlipi-
demia. He reported a distant history of tobacco-smoking.
The patient appeared well and was in no acute distress.
His physical examination was unremarkable except for an
elevated temperature of 102 degrees Fahrenheit. Blood
tests including complete blood count and differential,
thick and thin smears for malaria, and dengue serology
were normal. He was treated with oral clarithromycin 500
mg twice a day for one week. A second course of clarithro-
mycin for a period of 14 days was initiated two weeks later
for persistent fever and malaise, in addition to new com-
plaints of severe bone pain and weight loss. After six
weeks, the fever subsided and his constitutional symp-
toms improved.
A Computed tomography (CT) scan performed during his
fever evaluation revealed 2 pulmonary nodules: a 1.7 cm
left lower lobe nodule and a 1 cm right upper lobe nodule
(Figure 1). PET imaging revealed F-18 FDG uptake in the
left lower lobe nodule with an SUV of 3.8, CT-guided nee-
dle biopsy was non-diagnostic, and the patient was
referred to our hospital for further evaluation of suspected
lung cancer.
He underwent a right thoracoscopy with wedge resection
of the right upper lobe peripheral pulmonary nodule. His-
topathology revealed multiple granulomata with exten-
sive necrosis. Methenamine silver stains demonstrated
yeast consistent with histoplasma within the necrotic foci.
The patient was started on oral itraconazole capsules, 200
mg once a day.
After three months, a follow up CT scan confirmed exci-
sion of the right lung nodule but demonstrated enlarge-
ment of the left sided lung nodule from 1.7 cm to 3 cm
(Figure 2). Growth in a nodule with F-18 FDG uptake
raised concern regarding cancer despite the known history
of pulmonary histoplasmosis. The risks and benefits of
operative resection versus watchful waiting were discussed
with an interdisciplinary team, the patient, and his family.
The patient underwent a left lower lobectomy. Pathology
revealed necrotizing granulomata resembling that seen in
the prior biopsy; visible fungal elements consistent with
histoplasmosis were visible upon silver staining. Interest-
ingly, operative fungal cultures were negative, suggesting
the growth in the lesion was likely from host immune
response, not from progression of infection. The formula-
tion of the patient's itraconazole was changed to an oral
solution, 200 mg once a day for an additional three
months. A follow up CT scan at one year duration has not
shown any recurrence of disease.
Discussion
H. capsulatum is endemic to many parts of the world, in
particular Latin America and the areas of the Midwestern
and Southcentral United States [1,2]. It is found to prefer
moist soil as a habitat, mainly that contaminated by drop-
pings of birds and bats [3,4]. The pathogenesis of histo-
plasmosis infection starts with the disruption of the soil.
As a result, the hyphae and conidia of H. capsulatum
become aerosolized, inhaled and deposited into the lung.
There, the fungus is engulfed by macrophages and other
phagosomes, but eludes elimination by converting to the
yeast form. The yeast cells then reside and multiply within
the phagolysosomal vesicles, possibly through a mecha-
nism that elevates intraphagosomal pH [5,6]. In the
absence of cell mediated immunity (CMI), the yeasts con-
tinue to multiply and disseminate to involve organs of the
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Chest CT scan showing a 1.7 cm left lower lobe nodule (left), 
as well as, a three months follow up Chest CT scan demon-
strating enlargement of the left lower lobe nodule from 1.7 
cm to 3 cm (right).
Chest CT scan showing a 1 cm right upper lobe nodule Figure 1
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reticulo-endothelial system. Once CMI develops, in the
immunocompetent adult, the formation of a granuloma
begins and the intracellular yeasts are finally destroyed.
The clinical presentation of acute histoplasmosis usually
depends on the size of the inoculum and the immune
response of the host. The vast majority of infections are
asymptomatic or present as an influenza-like illness, with
cough, fever, and headache. Chest radiographic findings
typically demonstrate small areas of infiltrate or mediasti-
nal lymphadenopathy. With time, a granulomatous reac-
tion occurs with areas of caseating necrosis leading to the
appearance of a round mass of scar tissue that may or may
not be calcified, known as a histoplasmoma.
In patients with known underlying lung disease, such as
emphysema or COPD, a chronic form of pulmonary his-
toplasmosis may occur. This infection usually starts by the
colonization of diseased lung tissue in the upper zones,
and progresses gradually, leading to cavity formation and
scarring. Symptoms are characterized by a productive
cough, fever, hemoptysis, weight loss, and occasional
night sweats along with lung cavitations that may be seen
on chest radiographs, often mimicking tuberculosis.
Patients with inadequate CMI, such as those receiving
immunosuppressive therapy or those infected with the
Human Immunodeficiency Virus (HIV), may develop
progressive disseminated histoplasmosis, an often rapidly
progressive and fatal illness that presents with fever, ane-
mia, leukopenia, hepatosplenomegaly, central nervous
system involvement, and cardiac manifestations.
Several laboratory tests are useful in the diagnosis of infec-
tions caused by H. capsulatum. Culture samples of the
organism remain the gold standard for diagnosis. The
samples are usually recovered from bone marrow, liver,
sputum, and bronchoalveolar lavage. Histopathologic vis-
ualization using special stains such as Giemsa or Methen-
amine Silver stains also aids in the diagnosis and yields
very rapid results. Complement fixation is another test
used for the diagnosis of H. capsulatum, detecting both
mycelial and yeast antigens.
Most patients with the acute form of histoplasmosis do
not require antimicrobial therapy, as they remain asymp-
tomatic or improve spontaneously. Patients presenting
with the chronic form of histoplasmosis are usually
treated with itraconazole for 6–12 months as a first line of
treatment. Patients presenting with progressive dissemi-
nated histoplasmosis usually require induction therapy
with intravenous amphotericin B, although it has been
shown that some patients may respond to itraconazole as
a first line therapy [7]. Once stabilized, patients may be
switched from amphotericin B to itraconazole. Patients
with HIV who present with progressive disseminated his-
toplasmosis require life-long maintenance therapy.
Surgical intervention is occasionally required in patients
with histoplasmosis. The finding of a histoplasmoma pre-
senting as a lung nodule or mass on a chest X-ray or CT
scan often raises concern for malignancy, which may
require thoracoscopic or open lung biopsy to establish a
definitive diagnosis.
F-18 FDG PET imaging and semiquantitative analysis with
SUV is increasingly used in the work-up of pulmonary
nodules [8]. Though generally considered accurate and
clinically useful, there is considerable overlap in SUV val-
ues obtained from active granulomatous lesions and
malignant processes [9,10]. Most reports of PET imaging
in granulomatous disease are of mycobacterial infection
or sarcoidosis; review of the literature reveals scant infor-
mation on FDG-PET and SUV values pertaining to histo-
plasmosis [11-14]. In fact, this information is based on
the published experience of 7 patients only (Table 1).
This case illustrates the difficulty in differentiating active
histoplasmosis infection from malignancy. Despite
known pulmonary histoplasmosis infection, there
remained significant concern that the left lower lobe
lesion of the patient presented herein was a concurrent
malignancy, especially when the lesion grew in spite of
adequate antifungal therapy. An increase in FDG uptake,
with an SUV of 3.8, further raised this concern. A second
pulmonary resection was ultimately required to defini-
tively rule out malignancy in this otherwise healthy,
immunocompetent individual.
In conclusion, though a self-limited disease in most
patients, H. capsulatum infection continues to complicate
the evaluation of pulmonary nodules and often leads to
Table 1: Standard Uptake Values of FDG-PET in Histoplasmosis
Author No. of Patients SUV Pathology
Gupta, 1992 2 0.42 and 0.82 Histoplasmosis
Dewan, 1993 2 1.92 and 3.38 Caseating granuloma with Histoplasma
Lowe, 1998 1 5 Necrotizing granuloma with histoplasmosis
Croft, 2002 2 4.0 and 4.5 HistoplasmosisPublish with BioMed Central    and   every 
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surgical resection. PET imaging is likely not useful in
determining the correct clinical approach in this disease,
as false positives are quite common in granulomatous
lesions. Perhaps future advances in PET imaging or the use
of delayed scanning may increase the accuracy of this
modality for cancer detection in areas where histoplasmo-
sis is endemic.
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